Study guide

3.3 Electrolyte Disorders: Potassium, Sodium, Calcium & Phosphorus

Veterinary Technician Specialist in Emergency and Critical Care VTS ECC

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Overview, Triage & Point-of-Care Assessment

1.1 AVECCTN Examination Structure, Blueprint & Credentialing 1.2 Emergency Triage Systems, Primary Survey & Capsule Diagnostics 1.3 Point-of-Care Ultrasound (POCUS / TFAST / AFAST / VetBLUE) & Rapid Interventions

2 Chapter 2: Cardiovascular Emergencies & RECOVER CPR

2.1 RECOVER Guidelines: Basic Life Support (BLS) & Resuscitation Dynamics 2.2 Advanced Life Support (ALS): Emergency Pharmacopeia, Reversals & Defibrillation 2.3 Electrocardiogram (ECG) Interpretation & Antiarrhythmic Therapy 2.4 Congestive Heart Failure, Cardiac Tamponade & Feline Aortic Thromboembolism

3 Chapter 3: Fluid Therapy, Shock Resuscitation & Acid-Base Balance

3.1 Pathophysiology, Stages & Classification of Shock 3.2 Fluid Dynamics, Crystalloids, Colloids & Hypertonic Resuscitation 3.3 Electrolyte Disorders: Potassium, Sodium, Calcium & Phosphorus 3.4 Arterial & Venous Blood Gas Analysis & Acid-Base Disorders

4 Chapter 4: Respiratory Emergencies & Mechanical Ventilation

4.1 Upper Airway Obstruction: BOAS, Laryngeal Paralysis & Tracheal Collapse 4.2 Lower Airway, Pulmonary Parenchymal & Vascular Emergencies: Asthma, Contusions & ARDS 4.3 Pleural Space Disease, Emergency Thoracocentesis & Chest Tube Management 4.4 Oxygen Delivery Modalities, Capnography & Mechanical Ventilation Basics

5 Chapter 5: Gastrointestinal & Hepatic Emergencies

5.1 Gastric Dilatation-Volvulus (GDV): Resuscitation, Decompression & Critical Nursing 5.2 Acute Abdomen, Septic Peritonitis & Canine Parvoviral Enteritis 5.3 Acute Pancreatitis, Acute Hemorrhagic Diarrhea Syndrome & Mesenteric Volvulus 5.4 Acute Hepatic Failure, Hepatic Encephalopathy & Biliary Emergencies

6 Chapter 6: Anesthesia, Analgesia & Constant Rate Infusions

6.1 Emergency Anesthesia Protocols & High-Risk Patient Stabilization 6.2 Multimodal Analgesia, Pain Scoring Scales & Local/Regional Anesthesia 6.3 Constant Rate Infusions (CRIs): Formulations, Calculations & Monitoring 6.4 Anesthetic Complications: Hypotension, Hypothermia & Emergency Interventions

7 Chapter 7: Renal & Urinary Emergencies

7.1 Acute Kidney Injury (AKI): Pathophysiology, IRIS Staging & Renal Replacement Therapy 7.2 Feline Urethral Obstruction: Deobstruction, Electrolyte Crises & Post-Obstructive Diuresis 7.3 Uroabdomen & Lower Urinary Tract Trauma: Diagnosis & Resuscitation

8 Chapter 8: Hemolymphatic, Transfusion Medicine & Sepsis/SIRS

8.1 Transfusion Medicine: Blood Typing, Crossmatching & Component Therapy 8.2 Immune-Mediated Hemolytic Anemia (IMHA) & Immune-Mediated Thrombocytopenia (IMTP) 8.3 Sepsis, Systemic Inflammatory Response Syndrome (SIRS) & DIC 8.4 Oncologic Emergencies: Tumor Lysis Syndrome, Bleeding Masses & Hypercalcemia

9 Chapter 9: Environmental, Toxicological, Ophthalmic & Exotic Species Emergencies

9.1 Heatstroke, Severe Hypothermia & Thermal Burn Management 9.2 Envenomation Syndromes & Acute Anaphylaxis Management 9.3 Common Small Animal Toxicities: Chocolate, Xylitol, NSAIDs & Rodenticides 9.4 Neurotoxins, Ethylene Glycol, Plant Toxins & Extracorporeal Therapies 9.5 Ophthalmologic Emergencies: Proptosis, Acute Glaucoma, Corneal Perforation & Chemical Injury 9.6 Emergency Care of Exotic Companion Species: Rabbits, Rodents, Ferrets, Birds & Reptiles

10 Chapter 10: Neurological Emergencies

10.1 Status Epilepticus & Cluster Seizures: Emergency Protocols & Refractory Therapy 10.2 Traumatic Brain Injury (TBI), Intracranial Pressure (ICP) & Modified Glasgow Coma Scale 10.3 Acute Spinal Cord Emergencies: Intervertebral Disc Disease (IVDD) & Neuro-Localization

11 Chapter 11: Endocrine & Metabolic Crises

11.1 Diabetic Ketoacidosis (DKA) & Hyperosmolar Hyperglycemic State (HHS) 11.2 Acute Adrenocortical Crisis (Addisonian Crisis) & Hypoadrenocorticism 11.3 Thyroid Storm, Feline Hyperthyroid Crises & Severe Hypoglycemia

12 Chapter 12: Reproductive & Musculoskeletal Emergencies

12.1 Reproductive Emergencies: Dystocia, Pyometra & Puerperal Hypocalcemia 12.2 Musculoskeletal Trauma: Open Fractures, Luxations, Splints & Compartment Syndrome 12.3 Rhabdomyolysis, Crush Injury & Polytrauma Damage Control Resuscitation

13 Chapter 13: Advanced Critical Care Monitoring, Vascular Access & The Rule of 20

13.1 Central Venous Catheterization, Arterial Lines & Intraosseous Access 13.2 Hemodynamic Monitoring: Invasive vs. Non-Invasive Blood Pressure, CVP & Cardiac Output 13.3 Kirby's Rule of 20: Comprehensive Daily Critical Patient Evaluation Checklist

3.3 Electrolyte Disorders: Potassium, Sodium, Calcium & Phosphorus

Key Takeaways Explain This Topic AI

Hyperkalemia (> 5.5 mEq/L, critical > 7.0-8.0 mEq/L) produces predictable, lethal ECG progression: tall peaked T waves, flattened/lost P waves, widened QRS, sinoventricular rhythms, and ventricular fibrillation/asystole.

Emergency management of hyperkalemia follows a strict sequence: 10% Calcium Gluconate (0.5-1.0 mL/kg slow IV) immediately stabilizes the myocardial membrane but does NOT lower potassium; Regular Insulin + Dextrose (0.5 U/kg insulin + 2 g dextrose/unit) actively drives potassium into cells.

The absolute maximum safe rate of intravenous potassium supplementation is Kmax = 0.5 mEq/kg/hr; exceeding this rate risks fatal iatrogenic cardiac arrest.

Serum sodium derangements must NEVER be corrected faster than 0.5 mEq/L/hr (or ≤ 10-12 mEq/L per 24 hours) to prevent fatal cerebral edema (in hypernatremia) or myelinolysis/osmotic demyelination syndrome (in hyponatremia).

Critical hypophosphatemia (< 1.5 mg/dL) commonly arises in Refeeding Syndrome and post-insulin DKA therapy, precipitating acute intravascular hemolysis and respiratory muscle paralysis due to erythrocyte ATP/2,3-DPG depletion.

Last updated: August 2026

Electrolyte Disorders: Potassium, Sodium, Calcium & Phosphorus

VTS Core Concept: Electrolytes dictate cellular resting membrane potentials, neuromuscular excitability, cardiac conduction, and fluid osmolality. In the emergency room and ICU, acute electrolyte derangements are rapidly fatal if the veterinary technician fails to recognize their electrocardiographic hallmarks and execute strict, rate-controlled stabilization protocols.

1. Potassium ( K + K^+ K + ) Homeostasis & Derangements

Potassium is the primary intracellular cation ( [ K + ] I C F ≈ 140 − 150 mEq/L [K^+]_{ICF} \approx 140-150\text{ mEq/L} [ K + ] I CF ​ ≈ 140 − 150 mEq/L vs. [ K + ] E C F ≈ 3.5 − 5.5 mEq/L [K^+]_{ECF} \approx 3.5-5.5\text{ mEq/L} [ K + ] ECF ​ ≈ 3.5 − 5.5 mEq/L ). The high intracellular-to-extracellular ratio ( [ K + ] i n / [ K + ] o u t [K^+]_{in} / [K^+]_{out} [ K + ] in ​ / [ K + ] o u t ​ ) established by the N a + / K + Na^+/K^+ N a + / K + ATPase pump determines the resting membrane potential ( R M P RMP RMP ) of excitable cardiac and neuromuscular cells via the Nernst equation.

Hyperkalemia ( K + > 5.5 mEq/L K^+ > 5.5\text{ mEq/L} K + > 5.5 mEq/L , Severe/Critical > 7.0 − 8.0 mEq/L > 7.0-8.0\text{ mEq/L} > 7.0 − 8.0 mEq/L )

Etiologies

Urinary Obstruction & Uroabdomen: Feline urethral obstruction (FLUTD), ruptured urinary bladder/ureter, severe oliguric/anuric Acute Kidney Injury (AKI).

Hypoadrenocorticism (Addison's Disease): Aldosterone deficiency leads to renal sodium wasting and potassium retention; N a + : K + Na^+:K^+ N a + : K + ratio < 27 : 1 < 27:1 < 27 : 1 (highly suggestive) or < 20 : 1 < 20:1 < 20 : 1 (classic).

Severe Acidemia: Transcellular shift where extracellular H + H^+ H + enters cells to be buffered in exchange for intracellular K + K^+ K + shifting outward ( 0.1 unit drop in pH 0.1\text{ unit drop in pH} 0.1 unit drop in pH increases serum K + K^+ K + by ≈ 0.2 − 0.6 mEq/L \approx 0.2-0.6\text{ mEq/L} ≈ 0.2 − 0.6 mEq/L ).

Reperfusion Injury & Massive Tissue Necrosis: Feline aortic thromboembolism (FATE) following ischemic limb reperfusion, severe crush injuries, massive tumor lysis syndrome.

Progressive Electrocardiographic (ECG) Changes

As extracellular potassium rises, the resting membrane potential becomes less negative (partially depolarized), inactivating voltage-gated fast N a + Na^+ N a + channels and impairing myocardial conduction velocity. Normal ECG ==> K+ 5.5-6.5 mEq/L ==> K+ 6.5-7.5 mEq/L ==> K+ 7.5-8.5 mEq/L ==> K+ > 8.5 mEq/L

  • (Normal) (Tall, peaked (Prolonged P-R, (Lost P waves, (Sine-wave, V-Fib,
  • narrow T waves) Flattened P waves) Wide QRS: SVR) Asystole/PEA)

5.5 − 6.5 mEq/L 5.5 - 6.5\text{ mEq/L} 5.5 − 6.5 mEq/L : Tall, narrow, peaked ("tented") T waves with shortened Q-T interval.

6.5 − 7.5 mEq/L 6.5 - 7.5\text{ mEq/L} 6.5 − 7.5 mEq/L : Prolongation of the P-R interval, decreased P wave amplitude (flattening), widening of the QRS complex, ST segment depression or elevation.

7.5 − 8.5 mEq/L 7.5 - 8.5\text{ mEq/L} 7.5 − 8.5 mEq/L : Complete loss of P waves with widened, bizarre QRS complexes. The sinoatrial node continues to drive the ventricles through specialized internodal tracts without generating atrial depolarization—termed Sinoventricular Rhythm .

> 8.5 − 10.0 mEq/L > 8.5 - 10.0\text{ mEq/L} > 8.5 − 10.0 mEq/L : Development of a smooth, undulating Sine-Wave pattern , degrading into Ventricular Fibrillation, Pulseless Electrical Activity (PEA), or Ventricular Asystole.

Emergency Four-Tiered Hyperkalemia Stabilization Protocol

Step Drug & Dosage Route & Speed Onset & Duration Mechanism of Action Critical Clinical Notes

1. Membrane Stabilization 10% Calcium Gluconate ; 0.5 − 1.0 mL/kg 0.5-1.0\text{ mL/kg} 0.5 − 1.0 mL/kg ( 50 − 100 mg/kg 50-100\text{ mg/kg} 50 − 100 mg/kg ) Slow IV over 10 − 15 min 10-15\text{ min} 10 − 15 min with continuous ECG monitoring Onset: 1 − 3 min 1-3\text{ min} 1 − 3 min ; Duration: 20 − 30 min 20-30\text{ min} 20 − 30 min Increases threshold potential ( T P TP TP ), restoring normal gap between R M P RMP RMP and T P TP TP ; cardioprotective DOES NOT LOWER SERUM POTASSIUM. If bradycardia or worsening arrhythmia occurs during injection, STOP IMMEDIATELY .

2. Intracellular Shifting (Primary) Regular (Soluble) Insulin ; 0.5 U/kg 0.5\text{ U/kg} 0.5 U/kg IV + Dextrose 2 g/unit insulin 2\text{ g/unit insulin} 2 g/unit insulin Insulin IV push; Dextrose diluted 1:1 with sterile water IV push, then 2.5 − 5 % 2.5-5\% 2.5 − 5% Dextrose CRI Onset: 15 − 30 min 15-30\text{ min} 15 − 30 min ; Duration: 4 − 6 hours 4-6\text{ hours} 4 − 6 hours Insulin stimulates N a + / K + Na^+/K^+ N a + / K + ATPase, actively pumping K + K^+ K + into intracellular space Monitor blood glucose every 30 − 60 min 30-60\text{ min} 30 − 60 min to prevent severe hypoglycemia.

3. Intracellular Shifting (Secondary) Terbutaline ( 0.01 mg/kg 0.01\text{ mg/kg} 0.01 mg/kg SC/IM/IV) or Albuterol (nebulized/inhaler) Parenteral or Inhalation Onset: 15 − 30 min 15-30\text{ min} 15 − 30 min ; Duration: 2 − 4 hours 2-4\text{ hours} 2 − 4 hours β 2 \beta_2 β 2 ​ -agonist stimulation activates adenylate cyclase → \to → drives K + K^+ K + into cells Excellent adjunct in blocked cats where IV access is delayed or insulin unavailable.

4. Intracellular Shifting (Acidemic) Sodium Bicarbonate ; 1.0 − 2.0 mEq/kg 1.0-2.0\text{ mEq/kg} 1.0 − 2.0 mEq/kg Very slow IV over 15 − 20 min 15-20\text{ min} 15 − 20 min Onset: 30 min 30\text{ min} 30 min ; Duration: 2 − 3 hours 2-3\text{ hours} 2 − 3 hours Increases blood pH, forcing H + H^+ H + out of cells in exchange for K + K^+ K + shifting intracellularly Use ONLY if severe concurrent metabolic acidosis ( p H < 7.15 pH < 7.15 p H < 7.15 , [ H C O 3 − ] < 10 [HCO_3^-] < 10 [ H C O 3 − ​ ] < 10 ). Risks: hypocalcemia, hypernatremia.

Hypokalemia ( K + < 3.5 mEq/L K^+ < 3.5\text{ mEq/L} K + < 3.5 mEq/L , Severe < 2.5 mEq/L < 2.5\text{ mEq/L} < 2.5 mEq/L )

Etiologies: Prolonged anorexia, aggressive fluid diuresis with potassium-deficient fluids, GI loss (vomiting, diarrhea), DKA (osmotic diuresis + insulin therapy), hyperaldosteronism (Conn's syndrome in cats), post-obstructive diuresis.

Clinical Signs: Generalized skeletal muscle weakness, flat/curved posture, lethargy, hypoventilation due to diaphragmatic weakness. In cats, severe hypokalemia presents with pathognomonic Cervical Ventroflexion (inability to raise the head due to lack of nuchal ligament and weak neck extensor muscles).

⚠️ Critical Safety Rule: Potassium Infusion Ceiling ( K m a x K_{max} K ma x ​ )

Maximum IV Potassium Administration Rate: K m a x = 0.5 mEq/kg/hr K_{max} = 0.5\text{ mEq/kg/hr} K ma x ​ = 0.5 mEq/kg/hr

Never exceed 0.5 mEq/kg/hr 0.5\text{ mEq/kg/hr} 0.5 mEq/kg/hr under any circumstances. Infusing concentrated potassium faster than this rate produces sudden, lethal hyperkalemic cardiac arrest. Always ensure thorough mixing in fluid bags (never inject K C l KCl K Cl directly into an existing running line or patient catheter).

2. Sodium ( N a + Na^+ N a + ) Disorders & Osmotic Shifts

Sodium is the major extracellular cation ( [ N a + ] = 140 − 155 mEq/L [Na^+] = 140-155\text{ mEq/L} [ N a + ] = 140 − 155 mEq/L dog, 145 − 160 mEq/L 145-160\text{ mEq/L} 145 − 160 mEq/L cat) and the primary determinant of effective serum osmolality ( P o s m = 2 [ N a + ] + [ G l u c o s e ] / 18 + [ B U N ] / 2.8 Posm = 2[Na^+] + [Glucose]/18 + [BUN]/2.8 P os m = 2 [ N a + ] + [ Gl u cose ] /18 + [ B U N ] /2.8 ).

Hypernatremia ( N a + > 155 mEq/L Na^+ > 155\text{ mEq/L} N a + > 155 mEq/L dog, > 162 mEq/L > 162\text{ mEq/L} > 162 mEq/L cat)

Mechanisms: Pure water loss (diabetes insipidus, heatstroke, lack of water access), hypotonic fluid loss (renal, GI), or sodium gain (salt ingestion, hypertonic saline administration).

Cerebral Adaptation & Idiogenic Osmoles: Acute hypertonicity shrinks brain cells. Within 24 − 48 hours 24-48\text{ hours} 24 − 48 hours , brain cells synthesize and accumulate intracellular organic osmoles ( idiogenic osmoles : taurine, myo-inositol, glutamine) to restore brain cell volume.

Hyponatremia ( N a + < 135 mEq/L Na^+ < 135\text{ mEq/L} N a + < 135 mEq/L dog, < 140 mEq/L < 140\text{ mEq/L} < 140 mEq/L cat)

Mechanisms: Hypovolemic sodium loss (Addison's, pancreatitis, severe diarrhea), hypervolemic dilution (CHF, severe liver failure, nephrotic syndrome), or SIADH.

🛑 The 0.5 mEq/L/hr Rule of Sodium Correction

Never change serum sodium concentration faster than 0.5 mEq/L/hr 0.5\text{ mEq/L/hr} 0.5 mEq/L/hr (maximum 10 − 12 mEq/L 10-12\text{ mEq/L} 10 − 12 mEq/L change in a 24 hour 24\text{ hour} 24 hour period).

Rapid correction of chronic hypernatremia with hypotonic fluids causes water to rush into idiogenic osmole-laden brain cells, producing Fatal Cerebral Edema , brain herniation, and coma.

Rapid correction of chronic hyponatremia with hypertonic/isotonic fluids draws water violently out of brain cells, producing Myelinolysis / Central Pontine Myelinolysis (Osmotic Demyelination Syndrome) , leading to irreversible quadriplegia, pseudobulbar palsy, and death.

Clinical Protocol: Choose fluids with a [ N a + ] [Na^+] [ N a + ] within 10 − 15 mEq/L 10-15\text{ mEq/L} 10 − 15 mEq/L of the patient's current serum sodium. For severe chronic hyponatremia, add sterile water or formulate custom fluids to ensure slow, controlled correction.

  • 3. Calcium ( C a 2 + Ca^{2+} C a 2 + ) & Phosphorus ( P O 4 3 − PO_4^{3-} P O 4 3 − ​ ) Derangements
  • Calcium Dynamics: Ionized vs. Total Calcium

Distribution: 50 % 50\% 50% Ionized Calcium ( i C a 2 + iCa^{2+} i C a 2 + ) (the only physiologically active fraction), 40 % 40\% 40% protein-bound (principally to albumin), and 10 % 10\% 10% complexed to anions (citrate, phosphate, bicarbonate).

Acid-Base Influence: Acidemia displaces calcium from albumin, increasing i C a 2 + iCa^{2+} i C a 2 + ; alkalemia increases calcium binding to albumin, decreasing i C a 2 + iCa^{2+} i C a 2 + .

Hypocalcemia ( i C a 2 + < 1.0 mmol/L iCa^{2+} < 1.0\text{ mmol/L} i C a 2 + < 1.0 mmol/L )

Etiologies: Puerperal tetany / Eclampsia (post-partum nursing bitches), primary hypoparathyroidism, acute pancreatitis (fat saponification binding calcium), ethylene glycol toxicity (calcium oxalate precipitation), severe sepsis/SIRS, massive citrated blood transfusion.

Clinical Signs: Facial pruritus and rubbing, muscle twitches/fasciculations, stiff gait, tetany, hyperthermia, seizures, prolonged Q-T interval on ECG.

Emergency Therapy: 10% Calcium Gluconate ( 0.5 − 1.5 mL/kg 0.5-1.5\text{ mL/kg} 0.5 − 1.5 mL/kg slow IV over 15 − 20 minutes 15-20\text{ minutes} 15 − 20 minutes with continuous ECG monitoring). Once stabilized, initiate oral calcitriol and calcium carbonate.

Phosphorus & Refeeding Syndrome / DKA Hemolysis

Hypophosphatemia ( P O 4 < 2.0 mg/dL PO_4 < 2.0\text{ mg/dL} P O 4 ​ < 2.0 mg/dL , Critical < 1.0 − 1.5 mg/dL < 1.0-1.5\text{ mg/dL} < 1.0 − 1.5 mg/dL ):

Pathophysiology: In chronically starved patients (Refeeding Syndrome) or untreated Diabetic Ketoacidosis (DKA), reintroducing nutrition or administering insulin triggers massive cellular uptake of glucose and phosphorus for intracellular phosphorylation.

Clinical Crisis: Severe intracellular phosphate depletion exhausts erythrocyte ATP and 2,3-diphosphoglycerate (2,3-DPG) . Red blood cells lose membrane deformability, resulting in Acute Intravascular Hemolytic Anemia , severe Heinz body formation, metabolic encephalopathy, and diaphragmatic muscle weakness.

Treatment: Intravenous potassium phosphate or sodium phosphate CRI ( 0.01 − 0.03 mmol/kg/hr 0.01-0.03\text{ mmol/kg/hr} 0.01 − 0.03 mmol/kg/hr ) titrated to serum phosphorus levels.